Evonik Industries AG (EVK.DE), a German chemicals company, on Friday posted a decline in net income and sales for the first quarter of fiscal 2026.
For the three-month period, the company reported a net profit of EUR 125 million, less than EUR 233 million in the same period last year. Excluding items, income stood at EUR 158 million as against EUR 275 million a year ago. Adjusted EBITDA was EUR 475 million, down from EUR 560 million in the previous year.
Evonik reported sales of EUR 3.427 billion, less than EUR 3.777 billion last year. This decline in sales reflects unfavorable exchange rates, a 2% drop in sales volumes, and a 1% fall in prices.
Looking ahead, for the second quarter, the company expects a rise in adjusted EBITDA due to higher sales volumes in certain businesses as a result of the persisting conflict in the Middle East.
For the second quarter of fiscal 2026, Evonik anticipates adjusted EBITDA of EUR 550 million. For the second quarter of fiscal 2025, the company had recorded an adjusted EBITDA of EUR 509 million.
For fiscal 2026, Evonik has reaffirmed its adjusted EBITDA outlook of EUR 1.7 billion to EUR 2 billion.
For fiscal 2025, the company had posted adjusted EBITDA of EUR 1.87 billion.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.